Overview
ARKG market data
Price History
ARKG price chart · 1M
- O
- 46.80
- H
- 47.17
- L
- 46.64
- C
- 47.10
- Vol
- 162,723.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $46.80
- Previous Close
- $47.21
- Day High
- $47.17
- Day Low
- $46.64
- 52 Week High
- $50.53
- 52 Week Low
- $24.60
- 7 Day Return
- -1.04%
- 30 Day Return
- +14.18%
- 90 Day Return
- +42.08%
- 1 Year Return
- +73.03%
- Daily Notional Volume
- $7.7M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- 1.78 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $24.60 – $50.53 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap —.
Fund & Macro News
10 captured
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtThe Motley Fool ·
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting ForBenzinga ·
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are UnderratingThe Motley Fool ·
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?The Motley Fool ·
Why Is Natera Stock Gaining Tuesday?Benzinga ·